Try our beta test site
24 studies found for:    "Epidermolysis Bullosa Dystrophica" OR "dystrophic epidermolysis bullosa"
Show Display Options
Rank Status Study
1 Withdrawn Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention:
2 Terminated Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
3 Completed Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)
Condition: Epidermolysis Bullosa Dystrophica
Interventions: Drug: Polyphenon E before Placebo;   Drug: placebo before treatment
4 Recruiting Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
5 Completed Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
6 Withdrawn A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Interventions: Biological: HP802-247;   Other: Placebo
7 Completed Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention: Drug: Granulocyte Colony Stimulating Factor (GCSF)
8 Recruiting Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Interventions: Other: Allogeneic mesenchymal stem cells;   Device: Polyurethene Film
9 Active, not recruiting Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa
Condition: Recessive Dystrophic Epidermolysis Bullosa
Intervention: Drug: Mesenchymal stromal cells
10 Recruiting Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa
Condition: Recessive Dystrophic Epidermolysis Bullosa
Intervention: Drug: Gene-modified autologous fibroblasts
11 Unknown  Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Recessive Dystrophic Epidermolysis Bullosa
Interventions: Other: Blood collection;   Other: Skin biopsies
12 Recruiting A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Epidermolysis Bullosa Dystrophica, Recessive
Interventions: Genetic: FCX-007;   Drug: Sterile Saline
13 Recruiting Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Intervention: Genetic: LZRSE-Col7A1 Engineered Autologous Epidermal Sheets
14 Completed
Has Results
Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Interventions: Device: Helicoll;   Device: Standard of Care Dressings
15 Terminated
Has Results
Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
Conditions: Epidermolysis Bullosa, Junctional;   Epidermolysis Bullosa Dystrophica
Interventions: Device: Apligraf;   Other: Standard dressing regimen
16 Completed Short Term Observational Study in DEB Patients
Condition: Dystrophic Epidermolysis Bullosa
Intervention:
17 Recruiting Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa Patients With Nonsense Mutations
Condition: Recessive Dystrophic Epidermolysis Bullosa
Intervention: Drug: Gentamicin Sulfate
18 Enrolling by invitation Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients
Condition: Recessive Dystrophic Epidermolysis Bullosa
Interventions: Drug: Gentamicin;   Drug: Placebo
19 Withdrawn Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB
Condition: Dystrophic Epidermolysis Bullosa
Intervention: Procedure: Photodynamic therapy (PDT)
20 Recruiting Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.
Condition: Recessive Dystrophic Epidermolysis Bullosa
Intervention: Drug: Genetically corrected cultured epidermal autograft (ATMP)

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.